Corcept Therapeutics Inc. buy Canaccord Genuity Group Inc.
Start price
08.03.23
/
50%
€19.83
Target price
08.03.24
€30.31
Performance (%)
7.94%
End price
09.03.24
€21.40
Summary
This prediction ended on 09.03.24 with a price of €21.40. The BUY prediction by Canaccord_Genuity_Gr finished with a performance of 7.94%. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corcept Therapeutics Inc. | 15.180% | 15.180% | -38.064% |
| iShares Core DAX® | -1.673% | 2.237% | 16.344% |
| iShares Nasdaq 100 | -1.346% | 0.290% | 3.851% |
| iShares Nikkei 225® | -1.529% | 5.863% | 18.286% |
| iShares S&P 500 | -1.702% | 0.697% | 1.755% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Corcept Therapeutics Inc. diskutieren
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $33.00 to $32.00. They now have a "buy" rating on the stock.
Ratings data for CORT provided by MarketBeat
In the thread Trading Corcept Therapeutics Inc.
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten